![](/img/cover-not-exists.png)
PDG16 PREDICTING THE COST-EFFECTIVENESS OF GENERIC VERSUS BRAND DABIGATRAN USING PHARMACOMETRIC ESTIMATES AMONG PATIENTS WITH ATRIAL FIBRILLATION
Wang, C.Y., Kim, S., Lingineni, K., Schmidt, S., Diaby, K., Brown, J.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.695
Date:
May, 2019
File:
PDF, 379 KB
english, 2019